Brca2 Inactivation

BRCA2 Inactivation is a molecular event characterized by the loss or impairment of BRCA2 tumor suppressor gene function, resulting from genetic or epigenetic alterations that disrupt its role in DNA repair and genomic stability.

469

Publications

50.2K

Citations

3.5K

Authors

943

Institutions

Publications per year

2017–2026

116

Authors

3.5K

  1. SA
    Steven A. Narod

    University of Toronto, Canada

    23 publications · 7.1K citations

    22

    h-index

  2. SL
    Susan L. Neuhausen

    City of Hope, United States

    14 publications · 3.5K citations

    14

    h-index

  3. FJ
    Fergus J. Couch

    Mayo Clinic, United States

    13 publications · 4.5K citations

    13

    h-index

  4. AR
    Ashok R. Venkitaraman

    University of Cambridge, United Kingdom

    13 publications · 1.9K citations

    12

    h-index

  5. JE
    Jórunn E. Eyfjörd

    University of Iceland, Iceland

    12 publications · 3.4K citations

    12

    h-index

1–5 of 3.5K

Venues

  1. Breast Cancer Research and Treatment

    34 publications · 1.9K citations

    25

    h-index

  2. Oncogene

    23 publications · 1.9K citations

    20

    h-index

  3. Nature Genetics

    13 publications · 6.3K citations

    13

    h-index

  4. PubMed

    Repository · 13 publications · 694 citations

    12

    h-index

  5. British Journal of Cancer

    BJC · 12 publications · 1.1K citations

    12

    h-index

1–5